Scaling-up Hepatitis Testing to Achieve the SDGs: Challenges and Opportunities from the COVID-19 Response
To view recordings from the event, click here.
We invite you to join the Coalition for Global Hepatitis Elimination for this UN General Assembly Virtual Side Event that will bring together leading diagnostic organizations, country representatives, and public health institutions to discuss both the challenges and opportunities in hepatitis testing presented by COVID-19, in pursuit of the 2030 WHO elimination targets and SDG goals.
Key discussion areas will include:
*Capacity building for diagnostic testing in response to COVID-19
*The impact of COVID-19 on national capacity for hepatitis B and C testing
*Opportunities for leveraging COVID-19 testing capacity to strengthen testing for hepatitis B and hepatitis C
Confirmed speakers include:
*Dr. Catharina Boehme, CEO, Foundation for Innovative New Diagnostics (FIND)
*Dr. Mohammed Abdulaziz, Head, Division of Disease Control and Prevention, Africa CDC
*Dr. Faisal Sultan, Special Assistant to the Prime Minister, Focal Point on Hepatitis Elimination, Government of Pakistan
*Dr. Mengistu Erkie, Gastroentrologist, Addis Ababa University, President, Ethiopian Gastroenterology Association
*Dr. Hanna Aberra, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
*Dr. Youngmee Jee, WHO International Health Regulation (IHR) Emergency Committee on COVID-19 Outbreak, Former Director-General, Center for Infectious Disease Research, Korea National Institute of Health (NIH), Korea Centers for Disease Control and Prevention
*Dr. John W. Ward, Director, Coalition for Global Hepatitis Elimination
Learn more here.